Abstract：
BACKGROUND: Traditionally, radical prostatectomy (RP) has been considered a contraindication to minimally invasive inguinal hernia repair. Purpose of this systematic review was to examine the current evidence and outcomes of minimally invasive inguinal hernia repair after RP.
METHODS: Web of Science, PubMed, and EMBASE data sets were consulted. Laparoscopic transabdominal preperitoneal repair (TAPP), robotic TAPP (r-TAPP), and totally extraperitoneal (TEP) repair were included.
RESULTS: Overall, 4655 patients (16 studies) undergoing TAPP, r-TAPP, and TEP inguinal hernia repair after RP were included. The age of the patients ranged from 35 to 85 years. Open (49.1%), laparoscopic (7.4%), and robotic (43.5%) RP were described. Primary unilateral hernia repair was detailed in 96.3% of patients while 2.8% of patients were operated for recurrence. The pooled prevalence of intraoperative complication was 0.7% (95% CI 0.2-3.4%). Bladder injury and epigastric vessels bleeding were reported. The pooled prevalence of conversion to open was 0.8% (95% CI 0.3-1.7%). The estimated pooled prevalence of seroma, hematoma, and surgical site infection was 3.2% (95% CI 1.9-5.9%), 1.7% (95% CI 0.9-3.1%), and 0.3% (95% CI = 0.1-0.9%), respectively. The median follow-up was 18 months (range 8-48). The pooled prevalence of hernia recurrence and chronic pain were 1.1% (95% CI 0.1-3.1%) and 1.9% (95% CI 0.9-4.1%), respectively.
CONCLUSIONS: Minimally invasive inguinal hernia repair seems feasible, safe, and effective for the treatment of inguinal hernia after RP. Prostatectomy should not be necessarily considered a contraindication to minimally invasive inguinal hernia repair.
METHODS: Web of Science, PubMed, and EMBASE data sets were consulted. Laparoscopic transabdominal preperitoneal repair (TAPP), robotic TAPP (r-TAPP), and totally extraperitoneal (TEP) repair were included.
RESULTS: Overall, 4655 patients (16 studies) undergoing TAPP, r-TAPP, and TEP inguinal hernia repair after RP were included. The age of the patients ranged from 35 to 85 years. Open (49.1%), laparoscopic (7.4%), and robotic (43.5%) RP were described. Primary unilateral hernia repair was detailed in 96.3% of patients while 2.8% of patients were operated for recurrence. The pooled prevalence of intraoperative complication was 0.7% (95% CI 0.2-3.4%). Bladder injury and epigastric vessels bleeding were reported. The pooled prevalence of conversion to open was 0.8% (95% CI 0.3-1.7%). The estimated pooled prevalence of seroma, hematoma, and surgical site infection was 3.2% (95% CI 1.9-5.9%), 1.7% (95% CI 0.9-3.1%), and 0.3% (95% CI = 0.1-0.9%), respectively. The median follow-up was 18 months (range 8-48). The pooled prevalence of hernia recurrence and chronic pain were 1.1% (95% CI 0.1-3.1%) and 1.9% (95% CI 0.9-4.1%), respectively.
CONCLUSIONS: Minimally invasive inguinal hernia repair seems feasible, safe, and effective for the treatment of inguinal hernia after RP. Prostatectomy should not be necessarily considered a contraindication to minimally invasive inguinal hernia repair.
摘要：
背景：传统上，根治性前列腺切除术（RP）已被认为是微创腹股沟疝修补术的禁忌症。这项系统评价的目的是检查RP后微创腹股沟疝修补术的当前证据和结果。
方法：WebofScience，PubMed,和EMBASE数据集进行了咨询。腹腔镜经腹腹膜前修补术(TAPP),机器人TAPP(r-TAPP)，包括完全腹膜外（TEP）修复。
结果：总体而言，4655名患者（16项研究）接受TAPP，r-TAPP,包括RP后TEP腹股沟疝修补术。患者的年龄范围为35至85岁。开放（49.1%），腹腔镜（7.4%），和机器人（43.5%）RP被描述。96.3％的患者进行了原发性单侧疝修补，而2.8％的患者因复发而手术。术中并发症的合并发生率为0.7%（95%CI0.2-3.4%）。报告膀胱损伤和上腹部血管出血。转换为开放的合并患病率为0.8%(95%CI0.3-1.7%)。血清肿的估计汇总患病率，血肿,手术部位感染为3.2%（95%CI1.9-5.9%），1.7%（95%CI0.9-3.1%），和0.3%（95%CI=0.1-0.9%），分别。中位随访时间为18个月（范围8-48）。疝复发和慢性疼痛的合并患病率为1.1％（95％CI0.1-3.1％）和1.9％（95％CI0.9-4.1％），分别。
结论：微创腹股沟疝修补术似乎是可行的，安全,对RP术后腹股沟疝的治疗有效。前列腺切除术不一定被认为是微创腹股沟疝修补术的禁忌症。
方法：WebofScience，PubMed,和EMBASE数据集进行了咨询。腹腔镜经腹腹膜前修补术(TAPP),机器人TAPP(r-TAPP)，包括完全腹膜外（TEP）修复。
结果：总体而言，4655名患者（16项研究）接受TAPP，r-TAPP,包括RP后TEP腹股沟疝修补术。患者的年龄范围为35至85岁。开放（49.1%），腹腔镜（7.4%），和机器人（43.5%）RP被描述。96.3％的患者进行了原发性单侧疝修补，而2.8％的患者因复发而手术。术中并发症的合并发生率为0.7%（95%CI0.2-3.4%）。报告膀胱损伤和上腹部血管出血。转换为开放的合并患病率为0.8%(95%CI0.3-1.7%)。血清肿的估计汇总患病率，血肿,手术部位感染为3.2%（95%CI1.9-5.9%），1.7%（95%CI0.9-3.1%），和0.3%（95%CI=0.1-0.9%），分别。中位随访时间为18个月（范围8-48）。疝复发和慢性疼痛的合并患病率为1.1％（95％CI0.1-3.1％）和1.9％（95％CI0.9-4.1％），分别。
结论：微创腹股沟疝修补术似乎是可行的，安全,对RP术后腹股沟疝的治疗有效。前列腺切除术不一定被认为是微创腹股沟疝修补术的禁忌症。
